1. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan R, Goldsmith SJ. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.J Nucl Med 1989;30:599?604.
2. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary SH, Watson AD, Ganey WV, Morgan RA, Williams SJ. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging. Part 1. Pharmacology of technetium-99m ECD in nonhuman primates.J Nucl Med 1989;30: 1892?1901.
3. L�veill� J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging. Part 2. Biodistribution and brain imaging in humans.J Nucl Med 1989;30:1902?1910.
4. L�veill� J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m HMPAO in healthy human subjects.J Nucl Med 1992;33: 480?484.
5. Matsuda H, Li YM, Higashi S, Sumiya H, Tsuji S, Kinuya K, Hisada K, Yamashita J. Comparative SPECT study of stroke using Tc-99m ECD, I-123 IMP, and Tc-99m HMPAO.Clin Nucl Med 1993;18:754?758.